Navigation Links
FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
Date:5/13/2008

DELAND, Fla., May 13 /PRNewswire/ -- USHIFU, LLC, the clinical trial management provider for Focus Surgery, Inc. (Indianapolis, IN), is pleased to announce conditional written approval pending minor changes to the protocol from the FDA to begin a pivotal trial for the treatment of recurrent prostate cancer with the Sonablate(R) 500 in men who have failed external beam radiation therapy.

Dr. Herbert Lepor, Chairman of Urology at NYU School of Medicine and medical monitor for the trial said, "It is my pleasure to serve as the medical monitor for the prostate cancer clinical trial program evaluating the safety and effectiveness of the Sonablate(R) 500 HIFU device."

"I have personally reviewed the preliminary data and observed the Sonablate(R) 500 in action and I am impressed with this advanced technology for ablating the prostate. These rigorous clinical trials will help define the appropriate role of the Sonablate(R) 500 device in the treatment of prostate cancer," Lepor added.

This trial will be conducted at various sites across the U.S. and is expected to enroll approximately 202 subjects and 10 clinical centers. This clinical trial is based on results from the feasibility trial completed in October 2007 which enrolled 11 subjects from two clinical research sites within the U.S. Ten of the eleven subjects had failed external beam radiation therapy prior to participating in the clinical trial. The results of this feasibility trial provided a basis for the pivotal study. Additional studies are still needed to satisfy the safety and effectiveness standards, including long term outcomes, set by the FDA for marketing approval.

The Sonablate(R) 500 is not approved for use in the U.S. The Sonablate(R) 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate(R) 500 for the treatment of prostate canc
'/>"/>

SOURCE USHIFU, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
4. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
7. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
8. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
9. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
10. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
11. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014   Mast Therapeutics, Inc. ... today that Santosh Vetticaden, Chief Medical Officer and ... for personal reasons, in mid-September.  Edwin L. ... Aires Pharmaceuticals, which Mast acquired earlier this year, ... Company,s interim Chief Medical Officer.  Dr. Parsley previously ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... 2014 Does your doctor know what you,re smoking?  ... recommended marijuana to the over 112,000 currently registered patients under ... of the other roughly 20,300+ active physicians listed with the ... it – even though a poll in February 2014 showed ... have tried it. "With marijuana legalization underway, ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... 10, 2011 MAQUET Cardiovascular, a leading provider ... signed a three-year, dual-source contract with Premier Healthcare ... the Premier membership.  The contract includes the CS300 ... 50cc IABP Catheter, SENSATION® 7Fr. IABP Catheter and ...
... PRINCETON, N.J., Oct. 10, 2011 Pharmasset, Inc. (Nasdaq: ... two treatment arms to the ELECTRON trial of PSI-7977, ... chronic hepatitis C (HCV). The rapid and consistent antiviral ... to date provided the rationale for additional exploratory regimens ...
Cached Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps 2MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps 3Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C 2Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C 3Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C 4
(Date:8/31/2014)... Franklin, TN (PRWEB) August 31, 2014 ... continuing education course provides an in-depth analysis ... and treatment of selected shoulder complex conditions. Over ... utilizing case studies, clinical reasoning and problem solving ... algorithm-based examination format for the special tests of ...
(Date:8/31/2014)... 31 August 2014: Drinking tea reduces non-cardiovascular mortality by ... at ESC Congress today by Professor Nicolas Danchin from ... choose between tea or coffee it,s probably better to ... our way of life. Their effects on cardiovascular (CV) ... divergent results. We investigated the effects of coffee and ...
(Date:8/30/2014)... 2014: A new batteryless cardiac pacemaker based on ... was presented at ESC Congress 2014 today by ... not require battery replacement. , Mr Zurbuchen, a ... ARTORG, University of Bern, Switzerland, said: "Batteries are ... they reach a critically low energy level, physicians ...
(Date:8/30/2014)... MN (PRWEB) August 31, 2014 As ... in home renovation, especially spa style bathrooms and in-home ... (NASS) has observed an increase in interest not only ... the history, culture and health benefits of sauna. ... Finnleo , the North American Sauna Society provides a ...
(Date:8/30/2014)... 2014 UWDress.com, a distinguished wedding dress supplier, ... first range of fashionable outfits. Recently, the company has unveiled ... As an autumn special offer, all these brand new products ... , “We are excited to unveil the new and ... high quality products are available at low prices now. The ...
Breaking Medicine News(10 mins):Health News:North American Seminars Master Clinicians Advanced Shoulder Course Receives PT Continuing Education Course Approval in Georgia, Pennsylvania, Massachusetts and Virginia 2Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:As Interest in Saunas Increases, the North American Sauna Society Increases Outreach to Provide Education on History, Design, and Culture 2Health News:UWDress.com’s Beautiful Collection Of “Flowy Bridesmaid Dresses” Released 2
... See health and economic data like you,ve never ... statistics guru Hans Rosling will show how ... data. He will also illustrate how the convergence of ... countries into "Western" and "developing" categories an outdated concept.On ...
... Sports Medicine Provider Times Implementation to ... ALLENTOWN, Pa., May 21 Allscripts announced today that ... medicine in Pennsylvania,s Lehigh Valley, has selected the ... (EHR) and Practice Management (PM) ...
... , May 21 For the second year in ... fans to donate blood through the Red Cross by joining ... ) Red Cross Racing is a program designed to ... times they donate. Participants of this program can get points ...
... neuropathy than blood glucose levels, study suggests , , THURSDAY, ... levels of triglyceride fats are at increased risk of ... or damage of nerves that results in numbness, tingling ... researchers say. , A study by U.S. researchers ...
... A new study published online in Nature Immunology ... immunoglobulin (lg) alleles pair up in the nucleus at stages that ... and Igk) loci. Researchers led by Jane A. Skok ... of Medicine and a member of the NYU Cancer Institute, showed ...
... patient care with PDA-using nursing students in clinical ... illness, enlisting video games to improve analytical and ... myth-busting in advanced pain management courses are some ... at the first international Health Professions Education (HPE) ...
Cached Medicine News:Health News:Gapminder's Hans Rosling Brings Poverty, Health Data to Life at Wilson Center 2Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 2Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 3Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 4Health News:Coordinated Health Selects Allscripts Electronic Health Record and Practice Management to Improve Coordination of Patient Care 5Health News:NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two 2Health News:NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two 3Health News:High Blood Fats Tied to Diabetic Nerve Loss 2Health News:NYU School of Medicine pathology researchers solve another mystery in B lymphocyte development 2Health News:Health Professions Education Conference features 'Headspace Theater,' serious gaming, PDAs 2
... Rhe Vivid 7 system is GEs ... new level of image quality to echocardiography, ... diagnostic confidence to clinicians.,By listening to customer ... created the first ergonomically-designed cardiovascular system that ...
... the launch of the NCP-2, ACS proudly ... has given physicians more tools for assessing ... first and only complete ECP Treatment Report.,The ... software program that allows both physicians and ...
... Radi invented the guidewire-mounted pressure sensor ... PressureWire5 Sensor is the only sensor ... temperature and flow. With significantly improved ... as your primary guidewire, as well ...
... The revolutionary Powerheart AED G3-Automatic simplifies the rescue ... shock button. All that you have to do ... cardiac arrest. Once the defibrillation pads are attached ... heart rhythm, analyzes the rhythm using the patented ...
Medicine Products: